Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
01/2013
01/02/2013CN101827598B Pharmaceutical combination of opioid and prostaglandin compound
01/02/2013CN101801377B Anti-inflammatory composition
01/02/2013CN101659659B Pyridine derivative and medical application thereof
01/02/2013CN101658569B Medicament for treating itch and pain in anus and preparation method thereof
01/02/2013CN101511797B Benzimidazole modulators of VR1
01/02/2013CN101103044B Anti-alhpha 9 integrin antibody and the use thereof
01/02/2013CN101084195B 3-phenyl-pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
01/01/2013US8345963 System for image analysis in a network that is structured with multiple layers and differentially weighted neurons
01/01/2013US8343996 Azaquinolinone derivatives and uses thereof
01/01/2013US8343988 Inhibitors of histone deacetylase
01/01/2013US8343986 Matrix metalloproteinase inhibitors
01/01/2013US8343980 Quinazoles useful as modulators of ion channels
01/01/2013US8343763 Heterocyclic derivatives as modulators of ion channels
01/01/2013US8343554 Formulations for the treatment of arthritis conditions
01/01/2013US8343492 Method for blocking binding of CX3C chemokines using CX3C chemokine antibodies
12/2012
12/27/2012WO2012178160A2 Materials and methods for modulating immune responses
12/27/2012WO2012178127A2 Site-activated binding systems that selectively increase the bioactivity of phenolic compounds at target sites
12/27/2012WO2012178063A1 Compound and method for modulating opioid receptor activity
12/27/2012WO2012177903A2 Methods of treating cognitive impairment
12/27/2012WO2012177725A1 Metalloenzyme inhibitor compounds
12/27/2012WO2012177714A1 Substituted 6-aza-isoindolin-1-one derivatives
12/27/2012WO2012177658A2 Methods of treating and preventing staphylococcus aureus infections and associated conditions
12/27/2012WO2012177635A1 Metalloenzyme inhibitor compounds
12/27/2012WO2012177618A1 Prostaglandin receptor ep2 antagonists, derivatives, compositions, and uses related thereto
12/27/2012WO2012177606A1 Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as jak inhibitors
12/27/2012WO2012177603A2 Metalloenzyme inhibitor compounds
12/27/2012WO2012177497A1 Method to inhibit neuropathic pain by intrathecal injection of protein phosphatases
12/27/2012WO2012177251A1 Pharmaceutical compositions comprising iodine and steroid and uses thereof for sinus diseases
12/27/2012WO2012177081A2 Pharmaceutical composition for preventing and treating inflammatory disease containing an ardisia tinctoria extract or a fraction thereof as an active ingredient
12/27/2012WO2012176792A1 Pharmaceutical composition for inflammatory diseases, allergic diseases and autoimmune diseases
12/27/2012WO2012176155A1 Pharmaceutical composition for use against inflammation and pain
12/27/2012WO2012176061A1 Trpv1 antagonists including dihydroxy substituent and uses thereof
12/27/2012WO2012175594A1 Wheat germ extract obtained by protease hydrolysis and medical use thereof
12/27/2012WO2012175223A1 Cathepsin-binding compounds bound to a carrier and their diagnostic use
12/27/2012WO2012174730A1 Preparative method and use of zyj-d08a and its epimers as histone deacetylase inhibitors
12/27/2012WO2012174591A1 Prevention and treatment of acute inflammatory conditions
12/27/2012WO2012149265A3 Tolerogenic synthetic nanocarriers to reduce cytotoxic t lymphocyte responses
12/27/2012WO2012145119A3 Low inflammatory blended oils
12/27/2012WO2012142434A8 Aav mediated ctla-4 gene transfer to treat sjogren's syndrome
12/27/2012WO2012135597A3 Novel, protective, anti-inflammatory receptor and its use in preservation of mitochondrial function, wound healing and repair
12/27/2012WO2012128501A3 Pharmaceutical composition containing, as an active ingredient, m-3m3fbs, which is an activator of phospholipase c, for preventing or treating inflammatory diseases or infectious diseases
12/27/2012WO2012125749A3 INFLAMMATION AND AUTOIMMUNE DISORDER TREATMENT USING RARα SELECTIVE AGONISTS
12/27/2012WO2012112447A3 Histone deacetylase inhibitors and methods of use thereof
12/27/2012WO2012105815A3 Biodegradable paox microspheres having cationic properties
12/27/2012US20120331575 Transgenic non-human animals
12/27/2012US20120330224 Gas conditioning
12/27/2012US20120329990 B7-related nucleic acids and polypeptides useful for immunomodulation
12/27/2012US20120329875 Ibuprofen for Topical Administration
12/27/2012US20120329864 Synergistic effect of tocotrienols and curcumin
12/27/2012US20120329863 Isolation of a dual cox-2 and 5-lipoxygenase inhibitor from acacia
12/27/2012US20120329860 Uses of Beta-Nicotinamide Adenine Dinucleotide
12/27/2012US20120329850 Methods for treating retinopathy with extended therapeutic effect
12/27/2012US20120329849 Unit dose formulations of ketorolac for intranasal administration
12/27/2012US20120329846 Therapeutic agent for inflammatory bowel disease and tnf-alpha production inhibitor
12/27/2012US20120329843 Fatty acid amide hydrolase inhihibitors for treating pain
12/27/2012US20120329813 Pemirolast for the Treatment of Systemic Low Grade Inflammation
12/27/2012US20120329809 Purine compounds used as cb2 agonists
12/27/2012US20120329808 Dihydrothieno pyrimidines as akt protein kinase inhibitors
12/27/2012US20120329803 Dihydropteridinones, method for production and use thereof
12/27/2012US20120329802 Metalloenzyme inhibitor compounds
12/27/2012US20120329790 Dentinal Drug Delivery Composition
12/27/2012US20120329786 Compounds and therapeutic uses thereof
12/27/2012US20120329785 Novel kinase inhibitors
12/27/2012US20120329781 Combinations comprising alpha-2-delta ligands
12/27/2012US20120329780 Novel kinase inhibitors
12/27/2012US20120329774 Thieno-pyridine derivatives as mek inhibitors
12/27/2012US20120329773 Bicyclic ring system substituted amide functionalised phenols as medicaments
12/27/2012US20120329772 Amino-tetrazoles analogues and methods of use
12/27/2012US20120329759 Formulations and methods for vascular permeability-related diseases or conditions
12/27/2012US20120329758 Combined Treatment Utilizing VB-201
12/27/2012US20120329757 Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis
12/27/2012US20120329736 Treatment for gastrointestinal disorders using a selective, site-activated binding system
12/27/2012US20120329734 Mixture and infusion or drink solution
12/27/2012US20120329727 Treatment of uncoupling protein 2 (ucp2) related diseases by inhibition of natural antisense transcript to ucp2
12/27/2012US20120329720 Anti-inflammatory compounds and uses thereof
12/27/2012US20120329717 Novel omega conotoxin peptides
12/27/2012US20120329705 Compounds for proteasome enzyme inhibition
12/27/2012US20120329671 Methods of identifying obm modulators
12/27/2012US20120328718 Pharmaceutical compositions
12/27/2012US20120328712 Carbon monoxide releasing rhenium compounds for medical use
12/27/2012US20120328706 Polymer particle delivery compositions and methods of use
12/27/2012US20120328690 Amniotic Membrane Preparations and Purified Compositions and Anti-Inflammation Methods
12/27/2012US20120328675 Film preparation containing medicament with unpleasant taste
12/27/2012US20120328666 Oral delivery of peptide pharmaceutical compositions
12/27/2012US20120328661 Coumarin compounds as receptor modulators with therapeutic utility
12/27/2012US20120328643 Outer membrane vesicle (omv) vaccine comprising n. meningitidis serogroup b outer membrane proteins
12/27/2012US20120328637 Methods and compositions for modulating the activity of the interleukin-35 receptor complex
12/27/2012US20120328636 Kdr peptides and vaccines comprising the same
12/27/2012US20120328635 Chaperonin 10 variants
12/27/2012US20120328632 Inhibition of leukocyte adhesion
12/27/2012US20120328628 Antibodies to conformationally trapped proteins
12/27/2012US20120328627 Chemokine receptor antagonists and use thereof
12/27/2012US20120328617 Method for inhibiting angiogenesis
12/27/2012US20120328615 Anti-kir antibodies for the treatment of inflammatory and autoimmune disorders
12/27/2012US20120328613 Humanized anti-factor d antibodies and uses thereof
12/27/2012US20120328583 Treatment of pain using placental stem cells
12/27/2012US20120328574 P38 inhibitors
12/27/2012US20120328541 Anti-radical agents
12/27/2012US20120328540 Cysteinyl compounds, compositions and methods of use
12/27/2012US20120328539 Thickener Or Gellant For Oil Materials, Gel Composition Comprising Same, And Method Of Producing Cosmetic Material Or Topical Agent
1 ... 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 ... 1272